首页> 中文期刊> 《心血管康复医学杂志》 >血浆N末端脑钠肽前体,胱抑素C检测结合急性冠脉事件注册评分评估ACS患者心功能及预后的作用

血浆N末端脑钠肽前体,胱抑素C检测结合急性冠脉事件注册评分评估ACS患者心功能及预后的作用

         

摘要

Objective:To assess effect of detection of plasma N terminal pro brain natriuretic peptide (NT‐proBNP) and serum cystatin C (Cys C) combined Global Registry of Acute Coronary Events (GRACE) score on heart func‐tion and prognosis in patients with acute coronary syndrome (ACS) .Methods :According to GRACE score ,a total of 136 ACS patients were divided into low risk group (n=29) ,intermediate risk group (n=39) and high risk group (n=68) .Serum Cys C level and plasma NT‐proBNP level were measured in all groups .Incidence rate of major ad‐verse cardiovascular events (MACE) within three and six months was counted .Results:Among ACS patients ,com‐pared with low risk group ,there were significant rise in levels of NT‐proBNP [ (165.80 ± 51.62) ng/L vs .(193.13 ± 74.64) ng/L vs .(985.45 ± 152.69) ng/L] and Cys C [ (0.83 ± 0.38) mg/L vs .(0.9 ± 0.25) mg/L vs .(1.23 ± 0.23) mg/L] ,left ventricular end‐diastolic diameter [six months: (50 ± 3) mm vs .(55 ± 3) mm vs .(59 ± 5) mm] ,significant reduction in left ventricular ejection fraction [LVEF ,six months: (55 ± 7)% vs .(49 ± 5)% vs . (40 ± 7)% ] ,and significant rise in incidence rate of MACE (six months:2.94% vs .9.55% vs .30.88% ) ,and a‐bove indexes in high risk group were significantly higher than those of intermediate risk group except LVEF signifi‐cantly reduced , P<0.05 or <0.01 ;Pearson correlation analysis indicated that NT‐proBNP and Cys C levels were positively correlated with GRACE score (r=0.72 , P<0.05 ; r=0.65 , P<0.05) respectively .Conclusion:NT‐proBNP and Cys C level detection combined GRACE score could exactly response heart function and prognosis .%目的:血浆N末端脑钠肽前体,胱抑素C检测结合急性冠状动脉事件注册评分评估ACS患者心功能,主要不良心血管事件( M ACE )的作用.方法:入选 ACS 患者136例,根据 GRACE评分分为低(29例)、中(39例)、高危组(68例),检测各组血清Cys C及血浆 NT‐proBNP水平,心功能,统计3、6个月内 MACE发生率。结果:在ACS患者中,与低危组比较,中危组和高危组NT‐proBNP [(165.80±51.62) ng/L比(193.13±74.64) ng/L比(985.45±152.69) ng/L]、Cys C [(0.83±0.38) mg/L比(0.9±0.25) mg/L比(1.23±0.23) mg/L]水平显著升高,左室舒张末期内径[6个月:(50±3) mm比(55±3) mm比(59±5) mm]明显增加,左室射血分数[LVEF ,6个月: (55±7)%比(49±5)%比(40±7)%]显著降低,不良心血管事件发生率(6个月:2.94%比9.55%比30.88%)明显升高,且高危组上述各项(除LVEF显著降低外)均显著高于中危组, P<0.05或<0.01;Pearson相关分析显示, NT‐proBNP、Cys C水平与 GRACE危险积分分别呈正相关(r=0.72, P<0.05;r=0.65, P<0.05)。结论:NT‐proBNP及Cys C水平检测结合GRACE评分,能准确反映心功能、评估预后。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号